Abstract
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have